Adial Pharmaceuticals reported earnings of -$ 4.52 per AZR share on Nov 12, 2026, beating analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.34 |
| Earnings Per Share (Surprise) | -$ 4.52 (-$ 4.18) |
| Last Year's EPS | -$ 4.20 |
| EPS YoY Change |
Out of the last 45 earnings reporting periods, Adial Pharmaceuticals beat analysts’ expectations 9 times and fell short of expectations 18 time(s). Adial Pharmaceuticals reported earnings per share of -$ 4.52 in the last report falling to reach an estimated EPS of -$ 0.34 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.34 | -$ 4.52 | -$ 1.81 | |
| Aug 12, 2026 | -$ 1.03 | -$ 11.25 | -$ 2.00 | |
| May 13, 2026 | -$ 2.73 | -$ 1.48 | -$ 4.50 | |
| May 8, 2026 | -$ 2.73 | -$ 1.48 | -$ 8.50 | |
| Mar 10, 2026 | -$ 2.10 | -$ 1.81 | -$ 3.75 | |
| Nov 13, 2025 | -$ 2.25 | -$ 2.00 | -$ 9.50 | |
| Aug 13, 2025 | -$ 5.50 | -$ 4.50 | -$ 14.75 | |
| May 14, 2025 | -$ 12.50 | -$ 8.50 | -$ 17.00 | |
| Mar 4, 2025 | -$ 9.50 | -$ 3.75 | -$ 1.35 | |
| Nov 13, 2024 | -$ 12.50 | -$ 9.50 | -$ 28.50 | |
| Aug 13, 2024 | -$ 0.53 | -$ 14.75 | -$ 33.25 | |
| May 14, 2024 | -$ 0.51 | -$ 17.00 | -$ 2.63 | |
| Apr 4, 2024 | -$ 0.76 | -$ 1.35 | -$ 68.75 | |
| Nov 14, 2023 | -$ 28.50 | -$ 28.50 | -$ 3.00 | |
| Aug 21, 2023 | -$ 1.50 | -$ 33.25 | -$ 100.00 | |
| May 12, 2023 | -$ 0.14 | -$ 2.63 | -$ 81.25 | |
| Mar 30, 2023 | -$ 3.83 | -$ 68.75 | -$ 175.00 | |
| Nov 14, 2022 | -$ 0.18 | -$ 3.00 | -$ 137.50 | |
| Aug 16, 2022 | -$ 100.00 | -$ 100.00 | -$ 156.25 | |
| May 16, 2022 | -$ 106.25 | -$ 81.25 | -$ 187.50 |
Adial Pharmaceuticals’s stock was trading at $ 3.51 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, AZR’s price increased to $ 4.09 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 4.52 | $ 3.51 | $ 4.09 | |
| Aug 12, 2026 | -$ 11.25 | $ 4.31 | $ 4.39 | |
| May 13, 2026 | -$ 1.48 | $ 1.38 | $ 1.36 | |
| May 8, 2026 | -$ 1.48 | $ 1.42 | $ 1.44 | |
| Mar 10, 2026 | -$ 1.81 | $ 1.72 | $ 1.97 | |
| Nov 13, 2025 | -$ 2.00 | $ 8.25 | $ 8.25 | |
| Aug 13, 2025 | -$ 4.50 | $ 10.00 | $ 9.75 | |
| May 14, 2025 | -$ 8.50 | $ 15.75 | $ 16.50 | |
| Mar 4, 2025 | -$ 3.75 | $ 18.25 | $ 19.25 | |
| Nov 13, 2024 | -$ 9.50 | $ 25.50 | $ 28.50 | |
| Aug 13, 2024 | -$ 14.75 | $ 24.25 | $ 24.25 | |
| May 14, 2024 | -$ 17.00 | $ 36.25 | $ 35.50 | |
| Apr 4, 2024 | -$ 1.35 | $ 31.00 | $ 29.00 | |
| Nov 14, 2023 | -$ 28.50 | $ 50.25 | $ 53.00 | |
| Aug 21, 2023 | -$ 33.25 | $ 85.25 | $ 82.25 | |
| May 12, 2023 | -$ 2.63 | $ 200.00 | $ 200.00 | |
| Mar 30, 2023 | -$ 68.75 | $ 231.25 | $ 218.75 | |
| Nov 14, 2022 | -$ 3.00 | $ 175.00 | $ 181.25 | |
| Aug 16, 2022 | -$ 100.00 | $ 375.00 | $ 356.25 | |
| May 16, 2022 | -$ 81.25 | $ 800.00 | $ 925.00 |
Adial Pharmaceuticals released its most recent earnings reports in November 2026, August 2026, May 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Adial Pharmaceuticals missed analysts’ expectations during the last earnings period by
